Product Name | Strontium Ranelate |
---|---|
CAS | 135459-87-9 |
Formula | C12H6N2O8SSr2 |
MW | 513.49 |
Appearance | Light yellow to yellow powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
50 mg | In-stock | $150.00 | Visible after login | |
100 mg | In-stock | $225.00 | Visible after login | |
250 mg | In-stock | $355.00 | Visible after login |
Product Name | Strontium Ranelate |
---|---|
CAS | 135459-87-9 |
Formula | C12H6N2O8SSr2 |
MW | 513.49 |
Appearance | Light yellow to yellow powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis.
Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
PMID: 16735840 DOI: 10.1097/01.bor.0000229522.89546.7b
PMID: 17945546 DOI: 10.1016/j.bone.2007.08.043